 Rocio Pereira
Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adiponectin | 5 | 2016 | 235 | 1.360 |
Why?
| | Public Policy | 1 | 2023 | 67 | 0.840 |
Why?
| | Prejudice | 1 | 2023 | 69 | 0.840 |
Why?
| | Minority Groups | 2 | 2024 | 249 | 0.810 |
Why?
| | Insulin Resistance | 7 | 2017 | 1165 | 0.800 |
Why?
| | Blood Glucose Self-Monitoring | 2 | 2023 | 601 | 0.720 |
Why?
| | Blood Glucose | 5 | 2023 | 2097 | 0.570 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2439 | 0.540 |
Why?
| | Adipocytes | 3 | 2016 | 204 | 0.520 |
Why?
| | Attitude of Health Personnel | 1 | 2024 | 1094 | 0.520 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 110 | 0.490 |
Why?
| | Adiposity | 3 | 2015 | 504 | 0.490 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2008 | 360 | 0.470 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 566 | 0.460 |
Why?
| | Mexican Americans | 1 | 2015 | 113 | 0.460 |
Why?
| | Diabetes Mellitus | 2 | 2022 | 1000 | 0.410 |
Why?
| | Health Promotion | 2 | 2023 | 719 | 0.380 |
Why?
| | Medicare | 1 | 2017 | 706 | 0.370 |
Why?
| | Postmenopause | 3 | 2017 | 350 | 0.350 |
Why?
| | Racism | 2 | 2024 | 127 | 0.350 |
Why?
| | Diet | 1 | 2015 | 1212 | 0.290 |
Why?
| | Thiazolidinediones | 1 | 2008 | 137 | 0.280 |
Why?
| | Subcutaneous Fat | 2 | 2017 | 74 | 0.260 |
Why?
| | Weight Loss | 4 | 2017 | 732 | 0.240 |
Why?
| | Inpatients | 2 | 2023 | 462 | 0.230 |
Why?
| | United States | 6 | 2023 | 13828 | 0.230 |
Why?
| | Adult | 15 | 2024 | 35495 | 0.230 |
Why?
| | Humans | 27 | 2024 | 129248 | 0.230 |
Why?
| | Text Messaging | 2 | 2016 | 149 | 0.220 |
Why?
| | Supreme Court Decisions | 1 | 2023 | 11 | 0.220 |
Why?
| | Community Health Centers | 1 | 2024 | 57 | 0.220 |
Why?
| | Middle Aged | 16 | 2024 | 31087 | 0.220 |
Why?
| | Estradiol | 2 | 2017 | 494 | 0.210 |
Why?
| | Cultural Diversity | 1 | 2024 | 62 | 0.210 |
Why?
| | Prediabetic State | 2 | 2016 | 244 | 0.210 |
Why?
| | Food Assistance | 1 | 2023 | 29 | 0.200 |
Why?
| | Safety-net Providers | 1 | 2023 | 109 | 0.190 |
Why?
| | Interviews as Topic | 1 | 2024 | 704 | 0.180 |
Why?
| | Hypoglycemic Agents | 2 | 2012 | 1219 | 0.180 |
Why?
| | Estrogen Receptor beta | 2 | 2017 | 38 | 0.170 |
Why?
| | Postpartum Period | 1 | 2023 | 332 | 0.170 |
Why?
| | Obesity | 3 | 2023 | 2879 | 0.170 |
Why?
| | Female | 19 | 2024 | 68543 | 0.160 |
Why?
| | Feasibility Studies | 1 | 2023 | 867 | 0.160 |
Why?
| | Estrogen Receptor alpha | 2 | 2017 | 133 | 0.160 |
Why?
| | Patient Care Team | 1 | 2024 | 601 | 0.150 |
Why?
| | Cost of Illness | 1 | 2021 | 277 | 0.150 |
Why?
| | Medicaid | 1 | 2023 | 431 | 0.150 |
Why?
| | Overweight | 1 | 2023 | 531 | 0.150 |
Why?
| | Insulin | 4 | 2012 | 2325 | 0.150 |
Why?
| | Male | 14 | 2024 | 63501 | 0.150 |
Why?
| | Sleep Wake Disorders | 1 | 2021 | 251 | 0.150 |
Why?
| | Dietary Fats | 2 | 2018 | 301 | 0.150 |
Why?
| | Health Personnel | 1 | 2024 | 648 | 0.140 |
Why?
| | Delivery of Health Care | 2 | 2024 | 892 | 0.140 |
Why?
| | Critical Illness | 1 | 2023 | 757 | 0.140 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2017 | 41 | 0.140 |
Why?
| | 3T3-L1 Cells | 2 | 2008 | 34 | 0.140 |
Why?
| | Cross-Sectional Studies | 4 | 2021 | 5045 | 0.140 |
Why?
| | Qualitative Research | 1 | 2024 | 1215 | 0.140 |
Why?
| | Age Factors | 2 | 2017 | 3140 | 0.140 |
Why?
| | Body Fat Distribution | 1 | 2017 | 49 | 0.140 |
Why?
| | Pericardium | 1 | 2017 | 54 | 0.140 |
Why?
| | Human Development | 1 | 2016 | 16 | 0.130 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 132 | 0.130 |
Why?
| | Diabetes Mellitus, Type 1 | 2 | 2017 | 3628 | 0.130 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2017 | 93 | 0.130 |
Why?
| | Organ Specificity | 1 | 2016 | 295 | 0.130 |
Why?
| | Reproducibility of Results | 1 | 2023 | 3079 | 0.120 |
Why?
| | Diet Surveys | 1 | 2015 | 92 | 0.120 |
Why?
| | Adipose Tissue | 2 | 2017 | 590 | 0.120 |
Why?
| | Insurance Coverage | 1 | 2017 | 218 | 0.120 |
Why?
| | Puberty | 1 | 2016 | 143 | 0.120 |
Why?
| | Healthy Volunteers | 1 | 2015 | 200 | 0.120 |
Why?
| | Weight Gain | 1 | 2018 | 509 | 0.120 |
Why?
| | Receptors, Estrogen | 1 | 2017 | 426 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2015 | 138 | 0.110 |
Why?
| | Cohort Studies | 2 | 2017 | 5408 | 0.110 |
Why?
| | Sex Factors | 2 | 2017 | 1965 | 0.110 |
Why?
| | Language | 1 | 2017 | 283 | 0.110 |
Why?
| | Energy Metabolism | 2 | 2018 | 873 | 0.110 |
Why?
| | Socioeconomic Factors | 2 | 2017 | 1209 | 0.110 |
Why?
| | Stem Cells | 1 | 2016 | 574 | 0.100 |
Why?
| | Signal Transduction | 1 | 2005 | 4926 | 0.100 |
Why?
| | Logistic Models | 1 | 2017 | 1984 | 0.090 |
Why?
| | Abdominal Fat | 1 | 2012 | 40 | 0.090 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2012 | 160 | 0.090 |
Why?
| | Molecular Weight | 1 | 2012 | 328 | 0.090 |
Why?
| | Self Report | 1 | 2015 | 795 | 0.090 |
Why?
| | Glucose Clamp Technique | 1 | 2012 | 194 | 0.090 |
Why?
| | Patient Admission | 1 | 2012 | 181 | 0.090 |
Why?
| | Vascular Stiffness | 1 | 2015 | 467 | 0.090 |
Why?
| | Retrospective Studies | 3 | 2023 | 14455 | 0.080 |
Why?
| | Cell Differentiation | 1 | 2016 | 1887 | 0.080 |
Why?
| | Colorado | 2 | 2016 | 4406 | 0.080 |
Why?
| | Insulin Antagonists | 1 | 2008 | 8 | 0.080 |
Why?
| | Young Adult | 4 | 2023 | 12388 | 0.070 |
Why?
| | Androstadienes | 1 | 2008 | 106 | 0.070 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 1613 | 0.070 |
Why?
| | Sex Characteristics | 1 | 2012 | 736 | 0.070 |
Why?
| | Aged | 5 | 2017 | 22032 | 0.070 |
Why?
| | Enzyme Activation | 1 | 2008 | 812 | 0.070 |
Why?
| | Hypertension | 1 | 2015 | 1242 | 0.070 |
Why?
| | Blotting, Western | 1 | 2008 | 1204 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 151 | 0.060 |
Why?
| | Body Mass Index | 4 | 2017 | 2272 | 0.060 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 184 | 0.060 |
Why?
| | Pilot Projects | 2 | 2023 | 1584 | 0.060 |
Why?
| | Diet, Reducing | 1 | 2005 | 87 | 0.060 |
Why?
| | Biomarkers | 1 | 2015 | 3966 | 0.060 |
Why?
| | RNA, Messenger | 2 | 2016 | 2703 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2008 | 0.050 |
Why?
| | Cell Line | 1 | 2008 | 2779 | 0.050 |
Why?
| | Cystic Fibrosis | 1 | 2012 | 1053 | 0.050 |
Why?
| | Phobic Disorders | 1 | 2022 | 31 | 0.050 |
Why?
| | Transcription, Genetic | 1 | 2008 | 1416 | 0.050 |
Why?
| | Cells, Cultured | 1 | 2008 | 4076 | 0.040 |
Why?
| | Policy | 1 | 2022 | 143 | 0.040 |
Why?
| | Smoking Cessation | 1 | 2004 | 405 | 0.040 |
Why?
| | Mice | 2 | 2008 | 16915 | 0.040 |
Why?
| | Adolescent | 2 | 2016 | 20303 | 0.040 |
Why?
| | Poverty | 1 | 2023 | 496 | 0.040 |
Why?
| | Tomography Scanners, X-Ray Computed | 1 | 2017 | 19 | 0.030 |
Why?
| | Health Behavior | 1 | 2023 | 740 | 0.030 |
Why?
| | Follow-Up Studies | 2 | 2017 | 4886 | 0.030 |
Why?
| | Placebos | 1 | 2017 | 201 | 0.030 |
Why?
| | Cell Size | 1 | 2016 | 87 | 0.030 |
Why?
| | Intra-Abdominal Fat | 1 | 2017 | 88 | 0.030 |
Why?
| | Adipogenesis | 1 | 2016 | 50 | 0.030 |
Why?
| | Hospitalization | 2 | 2022 | 2052 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2022 | 575 | 0.030 |
Why?
| | Cell Phone | 1 | 2016 | 70 | 0.030 |
Why?
| | Sleep | 1 | 2021 | 684 | 0.030 |
Why?
| | Animals | 2 | 2008 | 35307 | 0.030 |
Why?
| | Cross-Over Studies | 1 | 2017 | 521 | 0.030 |
Why?
| | Treatment Outcome | 3 | 2016 | 10199 | 0.030 |
Why?
| | Vaccination | 1 | 2022 | 1347 | 0.030 |
Why?
| | Likelihood Functions | 1 | 2012 | 137 | 0.020 |
Why?
| | Exercise | 1 | 2023 | 1925 | 0.020 |
Why?
| | Texas | 1 | 2012 | 228 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1837 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2015 | 1875 | 0.020 |
Why?
| | Enteral Nutrition | 1 | 2012 | 188 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1736 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2017 | 3377 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2016 | 2374 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2021 | 5382 | 0.020 |
Why?
| | Insulin Infusion Systems | 1 | 2012 | 363 | 0.020 |
Why?
| | Lipids | 1 | 2012 | 625 | 0.020 |
Why?
| | Apoptosis | 1 | 2016 | 2498 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2537 | 0.020 |
Why?
| | Genotype | 1 | 2012 | 1835 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 6543 | 0.020 |
Why?
| | Basal Metabolism | 1 | 2005 | 58 | 0.010 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2012 | 2063 | 0.010 |
Why?
| | Dietary Carbohydrates | 1 | 2005 | 151 | 0.010 |
Why?
| | Hospitals, Urban | 1 | 2004 | 129 | 0.010 |
Why?
| | Phenotype | 1 | 2012 | 3074 | 0.010 |
Why?
| | Prospective Studies | 1 | 2015 | 7121 | 0.010 |
Why?
| | Fasting | 1 | 2005 | 267 | 0.010 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2515 | 0.010 |
Why?
| | Energy Intake | 1 | 2005 | 461 | 0.010 |
Why?
| | Urban Population | 1 | 2004 | 441 | 0.010 |
Why?
| | Child | 1 | 2016 | 20773 | 0.010 |
Why?
|
|
Pereira's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|